This review summarizes the evidence and challenges of using anticoagulation for stroke prevention in patients with concurrent atrial fibrillation and chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Anticoagulation decisions in AF with CKD remain uncertain; leaves open optimal strategies pending dedicated trials.
Khouri et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: